Literature DB >> 24814496

The prevalence, incidence, progression, and risks of aortic valve sclerosis: a systematic review and meta-analysis.

Sean Coffey1, Brian Cox2, Michael J A Williams3.   

Abstract

OBJECTIVES: The aim of this study was to comprehensively review the epidemiology of aortic sclerosis (ASc) and its association with cardiovascular events.
BACKGROUND: ASc, which is defined as thickening or calcification of the aortic valve without significant obstruction of blood flow, is a common finding on cardiac imaging.
METHODS: We searched MEDLINE and EMBASE from inception to April 2013 for studies describing the epidemiology of ASc and performed a meta-analysis of the risk of adverse events using a random effects model.
RESULTS: Twenty-two studies were identified from the systematic review. The prevalence of ASc increased in proportion to the average age of study participants, ranging from 9% in a study in which the mean age was 54 years to 42% in a study in which the mean age was 81 years. In total, 1.8% to 1.9% of participants with ASc had progression to clinical aortic stenosis per year. There was a 68% increased risk of coronary events in subjects with ASc (hazard ratio [HR]: 1.68; 95% confidence interval [CI]: 1.31 to 2.15), a 27% increased risk of stroke (HR: 1.27; 95% CI: 1.01 to 1.60), a 69% increased risk of cardiovascular mortality (HR: 1.69; 95% CI: 1.32 to 2.15), and a 36% increased risk of all-cause mortality (HR: 1.36; 95% CI: 1.17 to 1.59).
CONCLUSIONS: ASc is a common finding that is more prevalent with older age. Despite low rates of progression to ASc, there is an independent increase in morbidity and mortality associated with the condition.
Copyright © 2014 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  aortic valve sclerosis; aortic valve stenosis; epidemiology; heart valve diseases; meta-analysis; systematic review

Mesh:

Year:  2014        PMID: 24814496     DOI: 10.1016/j.jacc.2014.04.018

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  61 in total

1.  MicroRNA-214 promotes the calcification of human aortic valve interstitial cells through the acceleration of inflammatory reactions with activated MyD88/NF-κB signaling.

Authors:  Dongdong Zheng; Yue Zang; Haixia Xu; Yan Wang; Xiang Cao; Teng Wang; Min Pan; Jiahai Shi; Xiaofei Li
Journal:  Clin Res Cardiol       Date:  2018-12-05       Impact factor: 5.460

Review 2.  Genome-wide association studies of late-onset cardiovascular disease.

Authors:  J Gustav Smith; Christopher Newton-Cheh
Journal:  J Mol Cell Cardiol       Date:  2015-04-11       Impact factor: 5.000

3.  Large-scale community echocardiographic screening reveals a major burden of undiagnosed valvular heart disease in older people: the OxVALVE Population Cohort Study.

Authors:  Joanna L d'Arcy; Sean Coffey; Margaret A Loudon; Andrew Kennedy; Jonathan Pearson-Stuttard; Jacqueline Birks; Eleni Frangou; Andrew J Farmer; David Mant; Jo Wilson; Saul G Myerson; Bernard D Prendergast
Journal:  Eur Heart J       Date:  2016-06-26       Impact factor: 29.983

Review 4.  Biomarkers of Calcific Aortic Valve Disease.

Authors:  Aeron Small; Daniel Kiss; Jay Giri; Saif Anwaruddin; Hasan Siddiqi; Marie Guerraty; Julio A Chirinos; Giovanni Ferrari; Daniel J Rader
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-02-02       Impact factor: 8.311

5.  Growing importance of valvular heart disease in the elderly.

Authors:  Yan Chen; Kai-Hang Yiu
Journal:  J Thorac Dis       Date:  2016-12       Impact factor: 2.895

6.  Valvular heart disease in the elderly: more questions than answers.

Authors:  Sean Coffey; Bernard Prendergast
Journal:  J Thorac Dis       Date:  2017-01       Impact factor: 2.895

7.  A novel in vivo assessment of fluid dynamics on aortic valve leaflet using epi-aortic echocardiogram.

Authors:  Hideyuki Hayashi; Koichi Akiyama; Keiichi Itatani; Scott DeRoo; Joseph Sanchez; Giovanni Ferrari; Paolo C Colombo; Koji Takeda; Isaac Y Wu; Atsushi Kainuma; Hiroo Takayama
Journal:  Echocardiography       Date:  2020-01-31       Impact factor: 1.724

Review 8.  Calcific Aortic Valve Disease: Part 1--Molecular Pathogenetic Aspects, Hemodynamics, and Adaptive Feedbacks.

Authors:  Ares Pasipoularides
Journal:  J Cardiovasc Transl Res       Date:  2016-02-18       Impact factor: 4.132

9.  Association of low-density lipoprotein cholesterol-related genetic variants with aortic valve calcium and incident aortic stenosis.

Authors:  J Gustav Smith; Kevin Luk; Christina-Alexandra Schulz; James C Engert; Ron Do; George Hindy; Gull Rukh; Line Dufresne; Peter Almgren; David S Owens; Tamara B Harris; Gina M Peloso; Kathleen F Kerr; Quenna Wong; Albert V Smith; Matthew J Budoff; Jerome I Rotter; L Adrienne Cupples; Stephen Rich; Sekar Kathiresan; Marju Orho-Melander; Vilmundur Gudnason; Christopher J O'Donnell; Wendy S Post; George Thanassoulis
Journal:  JAMA       Date:  2014-11-05       Impact factor: 56.272

Review 10.  Adaptive immune cells in calcific aortic valve disease.

Authors:  Michael A Raddatz; Meena S Madhur; W David Merryman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-05-03       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.